Form 8-K - Current report:
SEC Accession No. 0001683168-22-004361
Filing Date
2022-06-15
Accepted
2022-06-15 08:47:05
Documents
3
Period of Report
2022-06-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT pharmacyte_8k.htm 8-K 19584
2 PRESS RELEASE pharmacyte_ex9901.htm EX-99.1 18074
3 GRAPHIC image_001.jpg GRAPHIC 8090
  Complete submission text file 0001683168-22-004361.txt   50251
Mailing Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653
Business Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653 (917) 595.2850
PharmaCyte Biotech, Inc. (Filer) CIK: 0001157075 (see all company filings)

EIN.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 001-40699 | Film No.: 221016687
SIC: 2836 Biological Products, (No Diagnostic Substances)